David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS), sold 8,519 shares at $25.00 ($206K) on 2026-06-10, disclosed to the SEC on 2026-06-12.
Scheduled sale ($206k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 2,170 | $54K | 26.3% |
| 2 | $23.93 | 6,349 | $152K | 73.7% |
| Total | $24.20 avg | 8,519 | $206K | 100% |
| Filing → |
| MLYS | SELL | 2026-07-15 | $557K | — | Filing → |
| MLYS | SELL | 2026-07-10 | $66K | — | Filing → |
| MLYS | SELL | 2026-06-17 | $350K | — | Filing → |